Technology | Lung Cancer | April 26, 2016

FDA Clears Philips CT Solutions for Lung Cancer Screening

Company’s full suite of low-dose CT solutions now cleared for lung cancer screening to promote early detection

Philips, low-dose CT, lung cancer screening, FDA approval

April 26, 2016 — Philips announced that any hospital or healthcare facility with one of its indicated computed tomography (CT) models can now become a lung cancer screening center. Philips’ suite of CT solutions has achieved 510(k) clearance from the U.S. Food and Drug Administration (FDA) for low-dose lung cancer screening (LCS).

The suite includes 27 CT and positron emission tomography (PET)/CT models, as well as integrated software and services.

Lung cancer is the leading cause of cancer death among both men and women in the United States, and the source of one in four cancer deaths. Screenings are recommended by the Center for Medicare & Medicaid Services (CMS) to help identify the disease earlier in high-risk populations when treatment can be more successful. Early detection using this method has been shown to not only improve prognosis and treatment but decrease death rates up to 20 percent. In addition, if diagnosed in stage one, patients can have up to a 49 percent chance of surviving, compared to a diagnosis at stage three where the survival rate is as low as 5 percent.

“Lung cancer is the No. 1 cancer killer in America, taking more American lives than colon, breast and prostate cancer combined, and early detection is key to fighting this terrible disease,” said Brady J. McKee, M.D., radiologist at Lahey Hospital and Medical Center, which features the largest clinical lung cancer screening program in the country. “The work Philips has done to improve a provider’s screening capability not only benefits individual patients, but hospitals at each step of their Lung Cancer Screening program implementation and execution, which is often a very complicated process that includes community outreach, physician education, patient and data management, and reporting.”

Philips’ low-dose CT solutions now give healthcare organizations of varying clinical and economic needs — from community hospitals to multi-facility health systems — the ability to build robust lung cancer screening programs. Through its integrated radiology solutions and services, Philips can work with healthcare executives to better assess availability of existing scanners and to establish an enterprise-wide lung cancer program that will deliver advanced patient care and access.

Philips lung cancer screening solutions also provide several benefits for patients and referring physicians, including:

  • Personalized management of radiation dose – The 27 models of Philips CT and PET/CT solutions qualified with the indications for use to perform CT lung cancer screening also utilize active dose management tools;
  • Greater insights throughout the process – Referring physicians are better able to manage the process from end-to-end through “control center” software tools that enable digital access to patient tracking data that proves insight into scheduling, results and follow-up activities; and
  • Advanced image data sharing and analytics – Through its IntelliSpace Portal, Philips offers a comprehensive solution for detection, diagnostics and therapy follow-up. To address the increasing interest in pulmonary care, the latest version, IntelliSpace Portal 8.0, now includes the new CT Lung Nodule Assessment (LNA) application designed for a more efficient and longitudinal workflow to provide additional clinical decision support. 

For more information:

Related Content

3-D Reconstruction of Ichthyosaurus Skull

A 3-D reconstruction of the ichthyosaurus skull from a computed tomography (CT) scan. Image courtesy of Nigel Larkin, taken at Royal Veterinary College, London.

News | Computed Tomography (CT) | January 09, 2019
A nearly meter-long skull of a giant fossil marine ichthyosaur found in a farmer's field more than 60 years ago has...
SCCT Releases New Guideline for CT Use During TAVR
News | Computed Tomography (CT) | January 08, 2019
The Society of Cardiovascular Computed Tomography (SCCT) has released a new expert consensus document for computed...
Artificial Intelligence Pinpoints Nine Different Abnormalities in Head Scans

A brain scan (left) showing an intraparenchymal hemorrhage in left frontal region and a scan (right) of a subarachnoid hemorrhage in the left parietal region. Both conditions were accurately detected by the tool. Image courtesy of Nature Medicine.

News | Artificial Intelligence | January 07, 2019
The rise in the use of computed tomography (CT) scans in U.S. emergency rooms has been a well-documented trend1 in...
CT Technique Expands Possibilities of Imaging Ancient Remains
News | Computed Tomography (CT) | December 27, 2018
Researchers in Sweden using computed tomography (CT) have successfully imaged the soft tissue of an ancient Egyptian...
Canon Aquilion One CT Helps Gates Vascular Institute Adhere to New Stroke Guidelines
News | Computed Tomography (CT) | December 12, 2018
In stroke, time saved on imaging is time gained in the treatment window. The recently updated guidelines from the...
Coreline Soft Introduces AI Lung Segmentation Solution at RSNA 2018
News | Lung Cancer | December 10, 2018
December 10, 2018 — Korean image software company Coreline Soft Co. Ltd.
FDA Approves New Features for Planmed Verity Cone Beam CT Scanner
Technology | Computed Tomography (CT) | December 07, 2018
The U.S. Food and Drug Administration (FDA) issued an approval letter for the new features and intended uses of the...
YITU Releases AI-Based Cancer Screening Solutions at RSNA 2018
News | Artificial Intelligence | December 06, 2018
Chinese artificial intelligence (AI) healthcare company YITU healthcare released two brand-new products, Intelligent...
Guerbet Launches Multi-Use OptiVantage Contrast Media Injector in Europe
Technology | Contrast Media Injectors | December 05, 2018
Contrast agent company Guerbet recently announced that the OptiVantage multi-use contrast media injector is now CE...
GE Healthcare Unveils New Applications and Smart Devices Built on Edison Platform
Technology | Artificial Intelligence | December 05, 2018
GE Healthcare recently announced new applications and smart devices built on Edison – a platform that helps accelerate...